Nano-based approaches for cancer therapeutics are undoubtedly important to tackle cancer. However, it is widely known that each cancer type has its own peculiarities and heterogeneity. This way, which are the main aspects / considerations you consider a "signature" and unique for each cancer type in what concerns nanomedicine-based therapies?
#cancer #nano #nanomedicine